PZ Cormay S.A.

Manufacture of other chemical products n.e.c.

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2006-12-19
Share capital
84,205,008.00 PLN
Activity description

Pz Cormay is a Polish manufacturer and distributor of high-quality diagnostic reagents and reliable IVD technology. The company offers a comprehensive range of laboratory analyzers and reagents for biochemistry, hematology, immunochemistry, and general analytics, serving small, medium, and large laboratories. Additionally, they provide integrated systems for point-of-care diagnostics and automation in hematological diagnostics.

Registered address
Wiosenna 22, 05-092 Łomianki, Poland
Email
Electronic delivery address
AE:PL-52127-43128-DFISD-33

Financials

Revenue history (in m)

Filing timeliness

Financial statements were filed on time, on average 41 days early. All were audited by a statutory auditor.

  • 202518/06/2026
  • 202426/05/2025
  • 202324/06/2024
  • 202226/06/2023
  • 202123/06/2022
  • 202001/07/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Stock quotes

PLN 0.48
+0.01 (+1.05%)
0.470.480.490.4810:0012:0014:0016:00
Open
PLN 0.47
High
PLN 0.49
Low
PLN 0.47
Volume
55.5K
Avg. vol.
48.4K
Market cap
PLN 40.67M
P/E ratio
–
EPS
-PLN 0.05
Shares outstanding
84.21M
52-week
PLN 0.45 – 0.51
Dividend yield
–
Dividend
–
Ex dividend date
–
Exchange
GPW Main Market

Quarterly results

PeriodRevenueEBITNet profit
Q2 2026USD 7.28mUSD 166.94kUSD -23.50k
Q1 2026USD 6.28mUSD -314.69kUSD -618.85k
Q4 2025USD 6.39mUSD -373.93kUSD -448.27k
Q3 2025USD 6.40mUSD 28.88kUSD -107.99k

Results for Q3 2026:Nov 27, 2026

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Sector · Manufacturing2,919 / 24,548
Top 12%
City · Łomianki9 / 294
Top 3.1%
Voivodeship · Mazowieckie3,472 / 76,892
Top 4.5%
Country · Poland11,961 / 297,069
Top 4.0%

Results vs industry

Revenue
This companyUSD 17.56mMedianUSD 638.23kAverageUSD 9.43m
Net profit
This companyUSD -1.37mMedianUSD 6.31kAverageUSD 97.67k
Operating costs
This companyUSD 18.17mMedianUSD 636.51kAverageUSD 9.00m
Assets
This companyUSD 23.81mMedianUSD 556.61kAverageUSD 6.76m

Websites

  • cormay.plStrona główna | Cormay Diagnostics
    LinkedIn AdsGoogle AnalyticsGoogle Tag ManagerApache
  • cormaydiagnostics.comCormay Diagnostics - IVD innovation and high quality technology for medicine
    LinkedIn AdsGoogle Tag ManagerApache
  • cormay.ruКормей Русланд — оборудование и реагенты для лабораторной диагностики | CORMAY
    WordPressElementorYoast SEONginx

Public procurement

214 tenders recorded as contractor: 125 national ($5,995,183) and 89 EU ($7,372,176).

SubjectAmount
Supply of specialised chemical reagents for Uniwersytet Przyrodniczy w Lublinie, divided into 14 lots + option.
–
Supply of disposable materials to SPZOZ w Choszcznie
$432
Supply of disposable materials to SPZOZ w Choszcznie
$432

Trademarks

The company holds 2 active trademarks registered with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 1992.

MarkNumberClassesStatusProtected until
CORMAY (word)Z.3338421, 3, 5, 9, 10, 35, 42Protected Dec 10, 2027
LIQUICK (word)Z.1668555, 9, 10, 42Protected Nov 22, 2026
CORMAY Z.1052190, 5Expired –
MarkProtected until
CORMAY (word)Dec 10, 2027
LIQUICK (word)Nov 22, 2026
CORMAY –

Job offers

The company has its own careers page: cormay.pl/kariera.

Authorized Representatives

Flavio Finotello age 63 – President of the Management Board
Robert Jaworowski age 61 – Attorney-in-fact
Wojciech Kamil Suchowski age 52 – Vice President of the Management Board

Manner of representation

Two members of the management board acting jointly or a member of the management board acting jointly with a commercial proxy are authorized to represent the company and make declarations on behalf of the company.

Supervisory board

Bartosz Aleksander Marczuk age 54 – Supervisory Board Member
Kamil Robert Gewartowski age 47 – Supervisory Board Member
Marcin Michał Murawski age 53 – Supervisory Board Member
Marcin Sieczek age 45 – Supervisory Board Member
Tomasz Markowski age 44 – Supervisory Board Member

Beneficial owners

PZ Cormay is a public company listed on the Warsaw Stock Exchange, so it does not report beneficial owners to the CRBR (Art. 58 of the Polish AML Act). Its shareholders are disclosed in stock-exchange reports.

Capital group

The company is the parent company of a corporate group.

NameCountry
Orphee SASwitzerland

Bank accounts

Registered as a VAT taxpayer on 2006-12-08.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

37 public aid cases recorded, with a total value of $2,146,947.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$1,960
De minimis aid (in accordance with Commission Regulation 2023/2831)
$27,012
De minimis aid (in accordance with Commission Regulation 2023/2831)
$801

European Funds

ProjectEU co-financing
Increasing the competitiveness of PZ Cormay S.A. by internationalising its offer at foreign trade fairs for the medical equipment sector Medlab2025
$59,983
Increasing the competitiveness of PZ Cormay S.A. by internationalizing its offer at foreign trade fairs for the medical equipment industry
$46,820
Implementation of research and development work on the development and market launch of a new Qube hematology analyzer
$305.2K

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Radiometer sp. z o.o.
Instytut Biotechnologii Surowic i Szczepionek Biomed - Skrót Firmy Ibss Biomed S.A.
Euroimmun Polska sp. z o.o.
Silesian Pharma sp. z o.o.
Pol-Eko A.Polok-Kowalska sp. k.
Hydrex Diagnostics sp. z o.o.
Biomerieux Ssc Europe sp. z o.o.
Biovena Health sp. z o.o.
Testchem sp. z o.o.
BIO-Ksel sp. z o.o.

Change history

DateEvent
2023-12-01PKD change
2018-10-31Share capital increase
2017-11-14Share capital increase
2015-09-25Share capital increase
2015-04-27PKD change

FAQ

Last updated: 2026-06-18